I-Kitfoustic Kit (iGolloidal Gold) ye-Igm Antibodv kwi-chimydia pneumoniae

Inkcazo emfutshane:


  • Ixesha lovavanyo:Imizuzu eli-10-15
  • Ixesha elifanelekileyo:Inyanga engama-24
  • I-Accuranity:Ngaphezulu kwe-99%
  • Ukucaciswa:I-1/6 yovavanyo / ibhokisi
  • Iqondo lokugcina:2 ℃ -30 ℃
  • Iinkcukacha zemveliso

    Iimpawu zeMveliso

    Ikhithi yokuqonda(IGolloidal igolide)kwi-IGM Antibodv kwi-chimydia pneumoniae
    Kwi-vitro diagostistik kuphela

    Nceda ufunde le phakheji Faka ngononophelo ngaphambi kokusetyenziswa kwaye ulandele ngokungqongqo imiyalelo. Ukuthembeka kweziphumo ze-Assay akunakuqinisekiswa ukuba kukho nakuphi na ukuphambuka kwimiyalelo kule mpahla yephakheji.

    Ukusetyenziswa kwenjongo
    Ikhithi yokuqonda. Isifo sekliniki. Ngeli xesha i-regent yovavanyo. Zonke iisampulu ezakhayo kufuneka zingqinwe zezinye iinkqubo zokuvavanywa.

    Ubungakanani bephakeji
    I-1 Kit / ibhokisi yebhokisi ye-10 / ibhokisi ye-10, i-skhit ezingama-25, / ibhokisi, i-ibhokisi ye-50 / ibhokisi / ibhokisi

    Isishwankathelo
    I-Chmlamydia Pneumoniae yi-pathogen ebalulekileyo yosulelo lokuphefumla, olunokubangela ukosuleleka kwephetshana, njenge-phectonitis, kunye ne-phectonitis, i-phectonia. I-CPN-I-IGM kwigazi liphela, i-serum okanye iplasma. The Diagnostic Kit is based on immunochromatography and can give a result within 15 minutes.

    Isixhobo esisebenzayo
    Ngaphandle kovavanyo olubonakalayo, i-kit inokutshatiswa kunye nohlaluko oluqhubekayo lwamajoni-i-A202 yeXiamen Wiz Biomech Coutech Co., ltd

    Inkqubo ye-Assay
    Inkqubo yovavanyo lweWiz-A202 yabona imiyalelo yokuphiliswa komzimba okuqhubekayo. INKQUBO YOKUFUNDA YOKUGQIBELA Imi eminye

    1.Teke ikhadi lovavanyo kwingxowa ye-foil, yibeke etafileni kwaye uyigawule;
    I-2ADD 8μl isampulu okanye isampulu yeplasma okanye i-20 i-20 yesampulu yegazi kwi-disceptte, emva koko yongeza i-100 ukuya kwi-2 ukuya kwi-2 ukuya kwi-2. Qala ixesha;
    I-3.Weit ubuncinci imizuzu eli-10-15 kwaye ifunde isiphumo, isiphumo asisebenzi emva kwemizuzu eli-15.


  • Ngaphambili:
  • Okulandelayo: